Development
Elevance Health, Inc.
ELV
$393.36
$8.712.26%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -33.59% | -30.44% | -6.84% | 129.94% | -46.04% |
| Total Depreciation and Amortization | -161.27% | -1.62% | -6.28% | 466.67% | -127.94% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -84.74% | 542.99% | 397.22% | -112.77% | 286.30% |
| Change in Net Operating Assets | -2,174.29% | 147.40% | -110.93% | 229.19% | -212.19% |
| Cash from Operations | -213.70% | 34.00% | -69.86% | 526.15% | -130.83% |
| Capital Expenditure | -2.19% | 8.86% | -16.28% | -1.01% | 2.30% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -77.78% | 723.08% | 99.21% | -6,200.00% | -85.71% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -60.58% | -45.31% | 75.18% | -303.10% | 166.06% |
| Cash from Investing | -49.78% | -2.23% | 78.89% | -1,201.73% | 123.18% |
| Total Debt Issued | 476.67% | 61.70% | -108.11% | 62.96% | 580.81% |
| Total Debt Repaid | 566.36% | 55.23% | 90.06% | -97.53% | -3,020.51% |
| Issuance of Common Stock | 29.03% | -18.42% | -11.63% | 43.33% | -16.67% |
| Repurchase of Common Stock | -93.33% | 25.81% | 10.14% | -26.32% | 2.06% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.57% | 0.57% | 0.28% | -15.08% | 0.33% |
| Other Financing Activities | -- | -100.00% | 50.00% | -92.00% | 316.67% |
| Cash from Financing | 60.36% | 30.49% | -169.30% | -105.81% | 79.44% |
| Foreign Exchange rate Adjustments | 125.00% | -500.00% | 0.00% | -50.00% | 133.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -573.38% | 714.57% | -105.48% | 285.52% | -161.47% |